Recent trials of antiplatelet therapy for stroke prevention indicate that the combination of
clopidogrel (75 mg/d) plus low-dose aspirin (75–162 mg/d) was not more effective than low …

Even though patients who develop ischemic stroke despite taking antiplatelet drugs
represent a considerable proportion of stroke hospital admissions, there is a paucity of data …

Objective: To investigate the short-term time course risks and benefits of clopidogrel with
aspirin in minor ischemic stroke or TIA. Methods: Data were derived from the Clopidogrel in …

After publication of this article [1], the authors contacted PLOS ONE to clarify that they did not
obtain prospective institutional review board approval to conduct their study. Upon editorial …

Ischaemic stroke and other atherothrombotic events substantially increase the medico-
economic burden because of their high treatment costs and long-lasting disabilities with …

Antiplatelet therapy is indicated for the treatment of ischemic stroke or transient ischemic
attack (TIA). Aspirin reduces subsequent occlusive vascular events, including recurrent …

Objective To evaluate the risks of recurrent stroke and major bleeding events with
clopidogrel and aspirin use among patients aged 80 years or older. Patients and Methods …

Background: In patients with acute minor ischemic stroke or high-risk transient ischemic
attack enrolled in the POINT trial (Platelet-Oriented Inhibition in New TIA and Minor Ischemic …

For patients with ischemic stroke or transient ischemic attack caused by
atherothromboembolism, immediate and long-term aspirin reduces the relative risk of …

Antiplatelet therapy is more effective than anticoagulation for the prevention of
noncardioembolic ischaemic stroke. The choice of antiplatelet regimen, however, remains …